Inozyme Pharma, Inc. (INZY) Financials
INZY Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 200.8 million | 60.4 million |
2023-09-30 | 205.7 million | 45.5 million |
2023-06-30 | 150.9 million | 45.3 million |
2023-03-31 | 141.8 million | 38.4 million |
INZY Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -18.6 million | 1.7 million |
2023-09-30 | -18.9 million | 1.7 million |
2023-06-30 | -15.6 million | 1.6 million |
2023-03-31 | -17.9 million | 2.1 million |
INZY Net Income
No data available :(
INZY Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 188.6 million | - | 1.8 million |
2023-09-30 | 192.4 million | - | 2.0 million |
2023-06-30 | 140.2 million | 31.9 million | 2.2 million |
2023-03-31 | 130.9 million | 24.2 million | 2.4 million |
INZY Shares Outstanding
INZY Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 105000 | 17.8 million | 4.8 million | 130000 |
2023-09-30 | 7000 | 13.3 million | 4.7 million | - |
2023-06-30 | 11000 | 11.7 million | 4.7 million | - |
2023-03-31 | 175000 | 11.9 million | 6.5 million | - |
INZY Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 306000 |
2023-09-30 | - | 333000 |
2023-06-30 | - | 331000 |
2023-03-31 | - | 324000 |
INZY
Price: $4.87
52 week price:
Earnings Per Share: -1.37 USD
P/E Ratio: -3.69
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 94105
Market Capitalization: 396.0 million